Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Diabetes
100%
Mitochondria
100%
Rapamycin
100%
Nicotinamide Adenine Dinucleotide (NAD+)
22%
Diabetology
22%
Signaling Pathway
11%
Mitochondrial Complex I
11%
Redox Balance
11%
Therapeutic Approaches
11%
Hyperglycemia
11%
Polyol Pathway
11%
Polymerase
11%
Adenosine Diphosphate Ribose
11%
Polyadenosine
11%
Regeneration
11%
Clinical Approach
11%
Chronic Administration
11%
Organ Transplant Patient
11%
New-onset Diabetes
11%
Redox Mechanism
11%
Complex I Dysfunction
11%
Reduced Nicotinamide Adenine Dinucleotide
11%
Target of Rapamycin Signalling
11%
Immune Rejection
11%
Diabetogenic
11%
Medicine and Dentistry
Diabetes
100%
Mitochondrion
100%
Mechanistic Target of Rapamycin
100%
Rapamycin
100%
Diabetogenesis
22%
Nicotinamide Adenine Dinucleotide
22%
Disease
11%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Signal Transduction
11%
Transplantation
11%
Hyperglycemia
11%
Poly ADP Ribose Polymerase
11%
Polyol Pathway
11%
Immunity
11%
Medical Decision Making
11%
Reduced Nicotinamide Adenine Dinucleotide
11%
Chronic Drug Administration
11%
Neuroscience
Mitochondrion
100%
Mammalian Target of Rapamycin
100%
Sirolimus
100%
Nicotinamide Adenine Dinucleotide
22%
Cell Signaling
11%
NADH Dehydrogenase (Ubiquinone)
11%
Hyperglycemia
11%
Polyol
11%
Poly ADP Ribose Polymerase
11%
Reduced Nicotinamide Adenine Dinucleotide
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Mammalian Target of Rapamycin
100%
Diabetogenesis
22%
Nicotinamide Adenine Dinucleotide
22%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Disease
11%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
11%
Hyperglycemia
11%
Reduced Nicotinamide Adenine Dinucleotide
11%
Polyol
11%